We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.90 | 2.80 | 2.90 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 13.09M | -33.29M | -0.0429 | -0.66 | 22.49M |
Date | Subject | Author | Discuss |
---|---|---|---|
21/11/2024 08:12 | They have a great product. So over time success should follow. | bunlop | |
21/11/2024 08:08 | Great update | imjustdandy | |
21/11/2024 08:08 | Just seen the RNS. Excellent. | purchaseatthetop | |
21/11/2024 07:54 | Desperate rampers will be pumping this On another fluffy quickly hashed rns. Happy sailing 🤦🏻 | ny boy | |
21/11/2024 07:45 | Agree that today's RNS was positive on all fronts & 'should ' be viewed positively. Our CEO & FD would have been aware of the 225 but that shouldn't have precluded them fro buying. Let's see what today brings | base7 | |
21/11/2024 07:38 | But then it reversed 8% the following day strange | best1467 | |
21/11/2024 07:28 | 225 is incredible. Shows the incompetence of Walbrook that they don't realise that should have been the headline and focus of the press release.Hopefully serves as a reminder to all how rife insider trading is on this stock. Someone obviously got wind of this on Tuesday hence their rush to take it up 10% just before the close | reviewwworld | |
21/11/2024 07:24 | Nice. May even recoup some of my losses here.. | bagpuss67 | |
21/11/2024 07:20 | No bad news is welcome and $225 selling price in October not sure anyone including the board saw that coming. Let’s hope the volume maintains trajectory | best1467 | |
21/11/2024 07:11 | Yip, good update, be nice to get this thread talking about the potential going forward rather than dwelling on previous failings and personal vendettas | eringael | |
21/11/2024 07:08 | I thought news coming hence the rise Good things are on track | qipincha | |
21/11/2024 07:07 | https://www.londonst | zeus19 | |
21/11/2024 07:07 | A very good RNS. | siggs44 | |
20/11/2024 21:05 | Factual evidence from AMARETTO with multiple usernames, now using WASHINGMACHINE? Priceless | antonagis | |
20/11/2024 20:31 | and anton Don’t for one minute think you are one of the big boys .. Run along now | washingmachine | |
20/11/2024 20:29 | Anton just remember your own past.. Or i will educate this board With factual evidence Now run along chap ! | washingmachine | |
20/11/2024 20:26 | Big boys don’t forget Bobarth Or his ex disciple AMARETTO, now WASHINGMACHINE | antonagis | |
20/11/2024 19:16 | Big boys never forget bobath ! 1 pence | washingmachine | |
20/11/2024 18:47 | Base. If AOP are going to pay 4p a share I am not sure they would allow Directors to buy at 2.7p now. Actually with that deal potentially coming the Directors would be in a closed period I think. The moment it is RNSd, if it happens as stated, the share price rises by 50%. | purchaseatthetop | |
20/11/2024 18:41 | As our share price drifts back towards its lows after yte brief excitement ,my thoughts turn back,again to the previus Proactive when our CEO hinted,in response to my question about Director share buying,that they were previously prohibited but could now buy shares .......yet none of them havent. If they believe in the potential of the company he & Santosh are running, they would surely be buying as many shares as they could afford if they consider our share price to materially understate our prospective value. Those in the know are not buying which emits a very poor signal. | base7 | |
20/11/2024 15:19 | Zeus. Pfizer have 11,000 sales reps and spend huge sums on marketing and promotion. The only realistic alternative is licensing. They tried that and it d not happen in the USA. | purchaseatthetop | |
20/11/2024 14:56 | What would you have done differently? I take it youre in the pharma business and have knowledge of how to market a new to market drug?? | zeus19 | |
20/11/2024 14:56 | Toffeeman. The problem they have had is that they had 30 sales persons till May 23 and then 100 max in 2024. With being maybe 5% under those figures and adding in training time, holidays, sickness etc they might have had effectively 65 FTE sales persons in 2024. That is only just over one per US state. So it takes a long time to get to the point where word of mouth or critical mass is hit. | purchaseatthetop |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions